You are here

  • Home
  • Archive
  • Volume 104, Issue Suppl 4
  • 13 A two-period, open-label trial evaluating the efficacy and safety of dasiglucagon for the treatment of children with hyperinsulinaemic hypoglycaemia

Article info

Article menu
Download PDFPDF
Abstracts
Physical Posters
13 A two-period, open-label trial evaluating the efficacy and safety of dasiglucagon for the treatment of children with hyperinsulinaemic hypoglycaemia

Authors

Citation

Morgan K, Taylor N, Carroll N, et al
13 A two-period, open-label trial evaluating the efficacy and safety of dasiglucagon for the treatment of children with hyperinsulinaemic hypoglycaemia
Archives of Disease in Childhood 2019;104:A5-A6.

Publication history

  • First published November 22, 2019.
Online issue publication 
November 22, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.